Medicine passport

MEZAVANT 1.2 g

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Mesalazine
Strength
1.2 g
Form
tablet (delayed- and extended-release)
ATC code
A07EC02
Registered in
Canada · Takeda Canada Inc
Prescription
Prescription only
DIN
02297558

Source: Drug Product Database · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

United States 15 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
Mesalamine1.2 g · Tablet, Delayed ReleasePrescription onlyLannett Company Inc. (+13)0527-3012
Lialda1.2 g · Tablet, Delayed ReleasePrescription onlyTakeda Pharmaceuticals America, Inc.54092-476

Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/ca/en/medicines/mezavant-1-2-g-tablet-delayed-and-extended-release